US Patent Issued on Aug. 26 for "Method of treating an ocular condition by administering multispecific antibodies that activates TIE2 and binds a receptor tyrosine kinase agonist" (Ohio Inventor)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,204, issued on Aug. 26.

"Method of treating an ocular condition by administering multispecific antibodies that activates TIE2 and binds a receptor tyrosine kinase agonist" was invented by Kevin Peters (Cincinnati).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides compositions comprising multi-specific compounds, including a compound that targets a phosphatase and a receptor tyrosine kinase agonist. Also provided are methods for the treatment of conditions associated with angiogenesis, comprising administering a multi-specific compound that targets a phosphatase and a receptor tyrosine kinase agonist."

The patent was filed on Dec...